Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
entresto 24 mg/26 mg filmsko obložene tablete
novartis europharm limited - valsartan, sakubitril - filmsko obložena tableta - valsartan 26 mg / 1 tableta; sakubitril 24 mg / 1 tableta - valsartan in sakubitril
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
entresto 49 mg/51 mg filmsko obložene tablete
novartis europharm limited - valsartan, sakubitril - filmsko obložena tableta - valsartan 51 mg / 1 tableta; sakubitril 49 mg / 1 tableta - valsartan in sakubitril
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
entresto 97 mg/103 mg filmsko obložene tablete
novartis europharm limited - valsartan, sakubitril - filmsko obložena tableta - valsartan 103 mg / 1 tableta; sakubitril 97 mg / 1 tableta - valsartan in sakubitril
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
entresto
novartis europharm limited - sacubitril, valsartan - odpoved srca - angiotensin ii antagonisti, druge kombinacije, agente, ki delujejo na renin-angiotensin sistem - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
neparvis
novartis europharm limited - sacubitril, valsartan - odpoved srca - sredstva, ki delujejo na sistem renin-angiotenzin - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.